ACURX PHARMACEUTICALS INC (ACXP) Stock Cash Flow
NASDAQ:ACXP - US00510M1045 - Common Stock
4.87 USD
-0.23 (-4.51%)
4.5 USD
-0.37 (-7.6%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.00M | -14.10M | -14.58M | -12.09M | -12.75M | |||
| Change In Working Capital | -22.50K | 284.10K | 1.01M | 1.25M | 140.00K | |||
| Other non cash items | 1.86M | 3.44M | 3.77M | 3.30M | 7.59M | |||
| OPERATING CASH FLOW | -8.16M | -10.38M | -9.80M | -7.54M | -5.01M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 7.87M | 6.62M | 8.16M | 3.70M | 14.80M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 7.87M | 6.62M | 8.16M | 3.70M | 14.80M | |||
| CHANGE IN CASH | -296.80K | -3.77M | -1.64M | -3.85M | 9.78M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.16M | -10.38M | -9.80M | -7.54M | -5.01M | |||
| FREE CASH FLOW | -8.16M | -10.38M | -9.80M | -7.54M | -5.01M | |||
All data in USD